Mark Barrett, CEO discusses the concept of 'Process Portability' and how it provides more options for your manufacturing. 👉https://ow.ly/H8TW50QG58s
About us
Vaccines, CGTs, and other advanced therapeutics are taking too long to reach patients. Scientists want to move faster, but external manufacturers prioritize ‘contracts’ over the need for innovation and speed in GMP manufacturing. The promise of patient-focused partnerships remains out of reach until now. *Speed through Science* VLE is led by the brightest scientific minds and powered by iACHIEVE© and BioACHIEVE© our digital and process science platforms. For every medicine, we redefine CMC, tech transfer, and GMP operations through digitization and scientific excellence creating a new frontier for medicine acceleration and a new state-of-the-art for GMP manufacturing. *Patient-Focused Partnerships* We constantly strive to understand the unique clinical and CMC landscape of every medicine we work on, enabling us to deliver the manufacturing breakthroughs our partners need to achieve audacious supply chain goals that truly serve patients. *Digital First GMP* Our expertise in manufacturing science and GMP operations is accentuated by our first-in-class digital strategy – iACHIEVE©. By digitizing our process, analytical and manufacturing science breakthroughs we can deliver medicines with the speed that patients deserve and the precision regulators demand.
- Website
-
http://www.vletherapeutics.com
External link for VLE Therapeutics
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Dublin
- Type
- Privately Held
- Founded
- 2021
Locations
-
Primary
Get directions
Dublin, IE
Employees at VLE Therapeutics
Updates
-
When it comes to clinical GMP manufacturing, you need a partner who can deliver results. Our team of process development scientists and GMP experts have the skills and experience to help you overcome any manufacturing challenge. https://lnkd.in/eua8qPCw
-
-
Discover how VLE Therapeutics sets the gold standard in lentiviral vector (LV) production. Our streamlined methods pave the way for next-generation therapeutics, delivering superior quality and efficiency. Learn more 👉 https://ow.ly/a5IJ50SeEr7
-
-
@Paul McCabe, COO, talks about VLE's depth of expertise and breadth of modality👉 http://ow.ly/GBN750NyPCy
-
Rein in and streamline process data, reports, risk assessments and more with our advanced digital CMC workflow platform ensuring resources & budgets are smartly deployed. https://lnkd.in/eua8qPCw
-
-
Looking for expert clinical GMP manufacturing support? Our world-class process development scientists and GMP teams have you covered. Trust us to solve any manufacturing needs and help bring your innovative therapies to patients. https://lnkd.in/eua8qPCw
-
-
Explore how VLE Therapeutics revolutionizes viral vector production, offering customized solutions to drive forward cutting-edge therapies. From meticulous design to seamless delivery, discover how our precision techniques unlock the full potential of viral vectors. Learn more on our services page. https://ow.ly/RRoK50SeCL0
-
Learn about the Medicine Accelerator and how it transforms the tech transfer process 👉https://lnkd.in/emfZHa-8
-
Congrats to Nicholas Donohue & Ana Luiza Pinto Queiroz, on sharing insightful work at Biochemical and Molecular Engineering XXIII, in Dublin over the past few days. Nicholas gave an oral presentation entitled "Optimized Manufacturing of Adeno-associated Virus for Gene Therapy" and Ana Luiza is hosting a technical poster on "Model and Simulation Workflow for Transfection Development" (Poster #22 through July 25). Learn more 👉https://ow.ly/Zi4q50SJ5Fu
-
-
Dive into VLE Therapeutics' innovative approach to adeno-associated virus (AAV) production. Our tailored strategies push the boundaries of efficacy, ensuring your AAV-based therapies stand out in the field. Explore our services page 👉 https://ow.ly/TBaf50SeE9I
-